SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA), as announced in a press release. The award recognizes the company's work in developing and commercializing robotic surgery technology. SS Innovations was selected over nine other finalists, including several established medical technology companies active in robotic surgery.
The recognition comes as adoption of the SSi Mantra surgical robotic system continues to expand. According to the company, more than 11,700 procedures have been completed globally using the system. Additionally, the SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s international growth strategy. More than 2,100 physicians have been trained on the platform, which has been used across more than 170 different procedures.
The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets. For investors, the award provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market.
Details of the award and the company’s progress can be found in the official announcement at https://ibn.fm/lDfv9. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
The impact of this recognition is significant for the surgical robotics industry. As more hospitals and surgical centers adopt robotic-assisted technologies, companies like SS Innovations are positioning themselves to capture market share. The SSi Mantra's regulatory approvals in 14 countries and the training of over 2,100 physicians indicate a growing ecosystem that could drive further adoption. With more than 170 different procedures performed using the system, the platform demonstrates versatility across multiple surgical specialties, potentially offering a competitive advantage.
For business leaders and technology executives, the award signals that SS Innovations is a key player to watch in the surgical robotics space. The company's ability to compete with established medical technology firms suggests that its technology and commercial strategy are gaining traction. As the global surgical robotics market continues to expand, companies that can achieve regulatory approvals, train physicians, and demonstrate clinical utility will be well-positioned for growth.
In summary, SS Innovations' recognition at the 2026 Surgical Robotics Industry Awards underscores the company's progress in commercializing its surgical robotic system and highlights the broader trend of increasing adoption of robotic-assisted surgery worldwide.
